Clinical trial
Bone Effect of Bortezomib in Patients With Relapsed/Refractory Multiple Myeloma
NCT01062230 is registered in ClinicalTrials.gov with University of Arkansas as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Bone Effect of Bortezomib in Patients With Relapsed/Refractory Multiple Myeloma
- Lead sponsor
- University of Arkansas
- Phase
- Phase 2
- Overall status
- Terminated
- Start date
- January 31, 2010
- Completion date
- August 31, 2013
- Enrollment
- 6 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.